MENU
ALZN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alzamend Neuro (ALZN) Ownership - Who owns Alzamend Neuro?
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
3480 Peachtree Road NE
Phone
+1 844 722-6333
Employees
7
Web
https://www.alzamend.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.73M
P/E Ratio
N/A
Total Cash
3.36M
Projected Growth
N/A
Total Debt
344.89K
Revenue
N/A
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
0.51
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ALZN
Capitalization
6.73M
P/E Ratio
N/A
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash
3.36M
Total Cash/Share
0.51
Total Debt
345K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.45M
P/B Ratio
1.95
Cash Flow
N/A
Earnings
-134.51
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
580
Current Ratio
5.44
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-4.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-170.50
Shares Held By Institutions
171K
Shares Outstanding - Current
6.6M
Total Liabilities
726K
Total Volume MTD
N/A
Value
N/A
Gain YTD
-12.069
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3480 Peachtree Road NE
Phone
+1 844 722-6333
Employees
7
Web
https://www.alzamend.com